-
公开(公告)号:DK0441207T3
公开(公告)日:1994-05-02
申请号:DK91101013
申请日:1991-01-26
Applicant: BASF AG
Inventor: AMMERMANN EBERHARD DR , LORENZ GISELA DR , LAUER MANFRED DR , GOETZ NORBERT DR , ZIPPERER BERNHARD DR , ZIERKE THOMAS DR
IPC: A01N43/40 , A01N43/54 , A01N43/58 , A01N43/60 , C07D213/30 , C07D213/50 , C07D401/06 , C07D405/06 , C07D407/06 , C07D409/06
Abstract: Heteroarylalkenes of the general formula I … …… … (Ar = heteroaryl, … A = C1-C6-alkyl, C2-C6-alkenyl, C3-C8-cycloalkyl, (C3-C8)-cycloalkyl-(C1-C3)-alkyl, mono-, di- or tricyclic substituted or unsubstituted aryl or aralkyl; … Z = … … where …… R = hydrogen, C2-C4-acyl, optionally substituted benzoyl, C1-C4-alkylsulphonyl, phenylsulphonyl which is unsubstituted or substituted by C1-C4-alkyl, or the radical R , … R is C1-C4-alkyl, substituted or unsubstituted phenyl or benzyl and … Hal is fluorine, chlorine, bromine or iodine; …… B is substituted or unsubstituted mono- or dicyclic aryl, aralkyl or heteroaryl) … and their N-oxides and acid addition salts; furthermore the preparation of these substances, intermediates therefor and their preparation, heteroarylalkene-containing fungicidal agents, and a suitable method for controlling fungal pests.
-
公开(公告)号:DE59001003D1
公开(公告)日:1993-04-15
申请号:DE59001003
申请日:1990-07-10
Applicant: BASF AG
Inventor: KOBER REINER DR , SEELE RAINER DR , ISAK HEINZ DR , HICKMANN ECKHARD DR , GOETZ NORBERT DR , ZIERKE THOMAS DR
IPC: C07B53/00 , C07C17/00 , C07C17/35 , C07C17/357 , C07C22/04 , C07C25/24 , C07C41/18 , C07C41/48 , C07C43/225 , C07C43/29 , C07D233/56 , C07D233/58 , C07D249/08 , C07D301/16 , C07D303/08 , C07D405/06 , C07D521/00
Abstract: Preparation of Z-1,2-diarylallyl chlorides of the general formula I in which the radicals R and R independently of one another are hydrogen, halogen, alkyl, haloalkyl, alkoxy, haloalkoxy or a substituted aromatic radical, and n and m represent 1, 2 or 3, by dehydrating chlorohydrins of the formula II in which the radicals have the abovementioned meanings, at temperatures of up to 50 DEG C in the presence of a carboxylic anhydride and of an organic or inorganic acid, in an inert ether or carboxylate as the solvent, the reaction of these products to give azolylmethyloxiranes, and novel intermediates.
-
公开(公告)号:DE3901327A1
公开(公告)日:1990-07-19
申请号:DE3901327
申请日:1989-01-18
Applicant: BASF AG
Inventor: ZIERKE THOMAS DR , SAUTER HUBERT DR , SCHULZ GUENTER DR , WILL WOLFGANG DR
IPC: C07C49/83 , C07D303/14 , C07F7/18
Abstract: Process for the preparation of 1-hydroxymethyloxiranes Z-substituted in position 2, of the general formulae I and ent-I, in which the substituents A and B independently of one another denote C1-C4-alkyl, phenyl, naphthyl, diphenyl or phenyl substituted by one to three radicals from the group comprising halogen, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-haloalkyl, nitro and phenoxy, in which ketones of the general formula II in which A and B have the abovementioned meanings and X stands for a group which can be eliminated under the reaction conditions, are reacted with trimethylsulphonium methylsulphate and a suitable base or with dimethyloxosulphonium methylide, and novel ketones of the general formula II' in which the substituents A' denotes phenyl or 4-fluorophenyl, B' denotes 2-fluorophenyl, 2-chlorophenyl, 2-bromophenyl or 2-trifluoromethylphenyl and X' denotes hydroxyl or a leaving group, with the proviso that B' does not stand for 2-chlorophenyl when A' denotes phenyl.
-
公开(公告)号:HU0004234A2
公开(公告)日:2001-05-28
申请号:HU0004234
申请日:1998-07-07
Applicant: BASF AG
Inventor: BARLOZZARI TERESA , HAUPT ANDREAS , JANSSEN BERND , KLING ANDREAS DR , ZIERKE THOMAS DR
Abstract: Compounds of the present invention include cell growth inhibitors which are peptides of Formula I, A-B-D-E-F-(G)r-(K)s-L (I), and acid salts thereof, wherein A, B, D, E, F, G and K are α-amino acid residues, and s and r are each, independently, 0 or 1. L is a monovalent radical, such as, for example, an amino group, an N-substituted amino group, a &bgr;-hydroxylamino group, a hydrazido group, an alkoxy group, a thioalkoxy group, an aminoxy group, or an oximato group. The present invention also includes a method for treating cancer in a mammal, such as a human, comprising administering to the mammal an effective amount of a compound of Formula I in a pharmaceutically acceptable composition.
-
公开(公告)号:CZ184698A3
公开(公告)日:1998-09-16
申请号:CZ184698
申请日:1996-12-11
Applicant: BASF AG
Inventor: AMBERG WILHELM DR , BARLOZZARI TERESA , BERNARD HARALD DR , BUSCHMANN ERNST DR , HAUPT ANDREAS DR , HEGE HANS-GUENTHER DR , JANSSEN BERND DR , KLING ANDREAS DR , LIETZ HELMUT , RITTER KURT DR , ULRICH MARTINA DR , WEYMANN JURGEN DR , ZIERKE THOMAS DR
Abstract: Novel peptides of the formula R R N-CHX-CO-A-B-D-E-(G)s-K in which R , R , A, B, D, E, G, K, X, and s have the meanings stated in the description, and the preparation thereof are described. The novel peptides have an antineoplastic effect.
-
16.
公开(公告)号:CZ24398A3
公开(公告)日:1998-07-15
申请号:CZ24398
申请日:1996-07-12
Applicant: BASF AG
Inventor: AMBERG WILHELM DR , BERNARD HARALD DR , BUSCHMANN ERNST DR , HAUPT ANDREAS DR , JANSSEN BERND DR , KARL ULRICH DR , KLING ANDREAS DR , MULLER STEFAN DR , RITTER KURT DR , ZIERKE THOMAS DR
IPC: C07K1/02 , C07K1/12 , C07K5/06 , C07K5/078 , C07K5/08 , C07K5/083 , C07K5/10 , C07K5/103 , C07K7/06
Abstract: PCT No. PCT/EP96/03073 Sec. 371 Date Jan. 13, 1998 Sec. 102(e) Date Jan. 13, 1998 PCT Filed Jul. 12, 1996 PCT Pub. No. WO97/05162 PCT Pub. Date Feb. 13, 1997A process for preparing pentapeptides of the formula I where A and R1-R3 have the stated meanings, comprises assembling the pentapeptide stepwise starting from a prolinamide of the formula II where R1 and R2 have the abovementioned meanings, and eliminating the group -NR1R2 by hydrolysis where appropriate the peptide obtained in this way.
-
公开(公告)号:DE19632773A1
公开(公告)日:1998-02-19
申请号:DE19632773
申请日:1996-08-14
Applicant: BASF AG
Inventor: MACK HELMUT DR , SEITZ WERNER DR , BAUCKE DORIT DR , LANGE UDO DR , HORNBERGER WILFRIED DR , HOEFFKEN HANS WOLFGANG DR , ZIERKE THOMAS DR
IPC: A61K38/00 , A61K38/05 , A61P7/02 , A61P29/00 , A61P35/00 , A61P35/04 , C07K5/06 , C07K5/062 , C07K5/065 , C07K5/078
Abstract: Compounds having formula (I) wherein A, B, E and D have the m eanings indicated in the description, are described, in addition to the production thereof. The substances can be used to combat illnesses.
-
18.
公开(公告)号:CZ9701537A3
公开(公告)日:1998-02-18
申请号:CZ153797
申请日:1995-11-25
Applicant: BASF AG
Inventor: BOHM HANS JOACHIM DR , KOSER STEFAN DR , MACK HELMUT DR , PFEIFFER THOMAS DR , SEITZ WERNER DR , HOFFKEN HANS WOLFGANG DR , HORNBERGER WILFRIED DR , ZIERKE THOMAS DR
IPC: A61K38/00 , A61K38/05 , A61P7/02 , C07K5/06 , C07K5/062 , C07K5/065 , C07K5/072 , C07K5/087 , A61K38/55
CPC classification number: C07K5/0812 , A61K38/00 , C07K5/06026 , C07K5/06043 , C07K5/06078 , C07K5/06113
-
公开(公告)号:CZ326096A3
公开(公告)日:1997-04-16
申请号:CZ326096
申请日:1995-04-26
Applicant: BASF AG
Inventor: AMBERG WILHELM DR , BERNARD HARALD DR , BUSCHMANN ERNST DR , HAUPT ANDREAS DR , JANITSCHKE LOTHAR DR , JANSSEN BERND DR , KARL ULRICH DR , KLING ANDREAS DR , MULLER STEFAN DR , DE POTZOLLI BERND DR , RITTER KURT DR , THYES MARCO DR , ZIERKE THOMAS DR
Abstract: PCT No. PCT/EP95/01577 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30691 PCT Pub. Date Nov. 16, 1995The compound Me2Val-Val-MeVal-Pro-Pro-NHBzlxHCl is described. It is prepared from Z-Val-Val-MeVal-Pro-OR1 where Z and R1 have the meanings stated in the description. The compound shows antineoplastic activity.
-
公开(公告)号:DE59009812D1
公开(公告)日:1995-11-30
申请号:DE59009812
申请日:1990-08-22
Applicant: BASF AG
Inventor: KOBER REINER DR , SEELE RAINER DR , ZIERKE THOMAS DR , ISAK HEINZ DR , KARBACH STEFAN DR , WEGNER GUENTER DR
Abstract: Preparation of ether solutions of arylmethylmagnesium halides… Ar-CH2-Mg-Hal I… (Aryl = unsubstituted or substituted aryl; Hal = Cl, Br) by the Grignard process from arylmethyl halides II… Ar-CH2-Hal II… with magnesium in an ether as a solvent, by using III… tert-butyl-O-R III… (R = C1-C3-alkyl) for this purpose.
-
-
-
-
-
-
-
-
-